CLINICAL_TRIALS
trial_result
· 2015-07-16
Clinical Trial Update: Prazosin for Smoking Cessation [Phase 2]
Summary
The Phase 2 trial of prazosin for smoking cessation in nicotine dependence was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre for Addiction and Mental Health | Conditions: Nicotine Dependence | Phase 2 | Status: TERMINATED